מנסווקס ACWY מנה בודדת
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
MENINGOCOCCAL VACCINES GROUP A 50 MCG/VIAL; MENINGOCOCCAL VACCINES GROUP C 50 MCG/VIAL
Available from:
GLAXO SMITH KLINE (ISRAEL) LTD
ATC code:
J07AH04
Pharmaceutical form:
POWDER FOR SOLUTION FOR INJECTION
Administration route:
S.C
Manufactured by:
GLAXO SMITH KLINE BIOLOGICALS S.A
Therapeutic group:
MENINGOCOCCUS, TETRAVALENT PURIFIED POLYSACCHARIDES ANTIGEN
Therapeutic indications:
For active immunization of adults and children over two eyars against meningococcal meningitis caused by meningococci of serogroups A, C,W 135 and Y meningococci.
Authorization date:
2009-09-01
